Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.7 USD | +3.76% | +8.18% | +20.61% |
May. 15 | Mizuho Raises Immatics' Price Target to $16 From $14, Keeps Buy Rating | MT |
May. 14 | Immatics' Q1 Loss Narrows. Revenue Rises | MT |
Business Summary
Number of employees: 484
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
T Cell Redirecting Immunotherapies
100.0
%
| 182 | 100.0 % | 58 | 100.0 % | -67.86% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Germany
100.0
%
| 182 | 100.0 % | 58 | 100.0 % | -67.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 50 | 99-12-31 | |
Arnd Christ
DFI | Director of Finance/CFO | 57 | 20-09-30 |
Chief Tech/Sci/R&D Officer | 49 | 20-05-31 | |
Steffen Walter
COO | Chief Operating Officer | 47 | 19-12-31 |
Investor Relations Contact | - | 19-08-31 | |
Tamara Louw
HRO | Human Resources Officer | - | 21-07-31 |
Miriam Meyer
LAW | General Counsel | - | 09-08-31 |
Maria Poulada
AUD | Comptroller/Controller/Auditor | - | 12-12-31 |
Ephraim Hofsäß
AUD | Comptroller/Controller/Auditor | - | 19-11-30 |
Claudia Blattner
PRN | Corporate Officer/Principal | - | 15-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Atieh
BRD | Director/Board Member | 70 | 20-06-30 |
Peter Chambré
CHM | Chairman | 68 | 12-09-30 |
Heather Mason
BRD | Director/Board Member | 63 | 20-06-30 |
Founder | 50 | 99-12-31 | |
Paul Carter
BRD | Director/Board Member | 63 | 20-06-30 |
Eliot Forster
BRD | Director/Board Member | 58 | 20-09-14 |
Adam Stone
BRD | Director/Board Member | 44 | 20-06-30 |
Mathias Hothum
BRD | Director/Board Member | 58 | 23-06-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 103,053,445 | 68,512,324 ( 66.48 %) | 0 | 66.48 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.61% | 1.31B | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- IMTX Stock
- Company Immatics N.V.